These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 35079988)

  • 1. Classic Psychedelic Drugs: Update on Biological Mechanisms.
    Vollenweider FX; Smallridge JW
    Pharmacopsychiatry; 2022 May; 55(3):121-138. PubMed ID: 35079988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.
    Vollenweider FX; Preller KH
    Nat Rev Neurosci; 2020 Nov; 21(11):611-624. PubMed ID: 32929261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics.
    Aqil M; Roseman L
    Neuropharmacology; 2023 Feb; 223():109300. PubMed ID: 36334767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
    Barbut Siva J; Barba T; Kettner H; Kuc J; Nutt DJ; Carhart-Harris R; Erritzoe D
    J Psychopharmacol; 2024 Feb; 38(2):145-155. PubMed ID: 38281075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care.
    Yaden DB; Earp BD; Griffiths RR
    Camb Q Healthc Ethics; 2022 Oct; 31(4):464-471. PubMed ID: 36398520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic applications of classical serotonergic psyche-delics: neurobiological mechanisms and neural networks].
    Seynaeve M; Van Besien A; van Elk M
    Tijdschr Psychiatr; 2023; 65(10):613-618. PubMed ID: 38174395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics.
    Kelmendi B; Kaye AP; Pittenger C; Kwan AC
    Curr Biol; 2022 Jan; 32(2):R63-R67. PubMed ID: 35077687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.
    Gobbi G
    J Psychiatry Neurosci; 2024; 49(5):E301-E318. PubMed ID: 39299781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
    Barksdale BR; Doss MK; Fonzo GA; Nemeroff CB
    Neurotherapeutics; 2024 Mar; 21(2):e00322. PubMed ID: 38278658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroscientific and psychological explanations for the therapeutic effects of psychedelics].
    van Elk M
    Tijdschr Psychiatr; 2020; 62(8):677-683. PubMed ID: 32816296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenomenology, Structure, and Dynamic of Psychedelic States.
    Preller KH; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():221-256. PubMed ID: 28025814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.
    Olson DE
    Biochemistry; 2022 Feb; 61(3):127-136. PubMed ID: 35060714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of psychedelics for the treatment of Alzheimer's disease and related dementias.
    Winkelman MJ; Szabo A; Frecska E
    Eur Neuropsychopharmacol; 2023 Nov; 76():3-16. PubMed ID: 37451163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Psychedelics Facilitate Emergence of Unconscious Psychological Processes?
    Lindegaard T
    Psychodyn Psychiatry; 2023 Sep; 51(3):270-286. PubMed ID: 37712665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.